Novo Nordisk's U.S.-listed shares fell Monday morning following the release of data for a new phase 3 clinical trial of its in-development weight loss drug CagriSema.

Novo Nordisk said CagriSema appeared to have a safe and well-tolerated profile in the latest trial. The most common adverse events were gastrointestinal, and the vast majority were mild to moderate ...

If you are experiencing constipation during your weight loss journey, here are some tips to consider adopting. 1. Eat a High-Fiber Diet. A high-fiber diet rich in whole grains, ve ...

Dr Jack and his mother Dr Clare Bailey Mosley are publishing new books as they continue Dr Michael Mosley's work ...

Novo Nordisk’s vision of 25%-plus weight loss is looking further and further away. | Novo Nordisk’s vision of 25%-plus weight ...

Most HHS workers were emailed an offer to leave their job for as much as $25,000 as part of President Trump’s government cuts ...

This spice may boost overnight fat burning and target belly fat by optimizing metabolism while you sleep. Discover how it ...

The late TV doctor’s wife Dr Clare Bailey Mosley is also bringing out a cookbook titled Eating Together: A Recipe For ...

Sea moss gel is a natural, gel-like substance made from sea moss, a type of red algae. It's rich in nutrients, including iron ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

It seems like no matter what I do, I can't lose weight. Most of my family members struggle with their weight too. Do our ...